Cargando…
Tumor Immune Microenvironment and Immunotherapy in Brain Metastasis From Non-Small Cell Lung Cancer
Brain metastasis (BM), a devastating complication of advanced malignancy, has a high incidence in non-small cell lung cancer (NSCLC). As novel systemic treatment drugs and improved, more sensitive imaging investigations are performed, more patients will be diagnosed with BM. However, the main treatm...
Autores principales: | Wang, Yuchang, Chen, Rui, Wa, Yue, Ding, Shikuan, Yang, Yijian, Liao, Junbo, Tong, Lei, Xiao, Gelei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891382/ https://www.ncbi.nlm.nih.gov/pubmed/35251014 http://dx.doi.org/10.3389/fimmu.2022.829451 |
Ejemplares similares
-
Targeting choroid plexus epithelium as a novel therapeutic strategy for hydrocephalus
por: Yang, Yijian, et al.
Publicado: (2022) -
Vascular Microenvironment, Tumor Immunity and Immunotherapy
por: Lamplugh, Zachary, et al.
Publicado: (2021) -
Immunotherapy: Reshape the Tumor Immune Microenvironment
por: LV, Bingzhe, et al.
Publicado: (2022) -
Tumor Microenvironment Evaluation for Gastrointestinal Cancer in the Era of Immunotherapy and Machine Learning
por: Ye, Zilan, et al.
Publicado: (2022) -
Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma
por: Yan, Dongming, et al.
Publicado: (2022)